Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

sartorius australia pty ltd - ct945 - general laboratoryware ivds - vivaspin / vivaspin turbo centrifugal concentrators are intended for the concentration and/or purification of macromolecules from dilute samples of serum, urine, cerebrospinal fluid and other body fluids prior to analysis.

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

baxter vaccine ag - tbe virus antigen - suspension for injection - %v/v

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - tick-borne encephalitis virus (inactivated) neudoerfl - suspension for injection in pre-filled syringe - 0.25 millilitre(s) - encephalitis vaccines; encephalitis, tick borne, inactivated, whole virus - encephalitis vaccines - it is indicated for the active (prophylactic) immunization of children aged from 1 year to 15 years against tick-borne encephalitis (tbe).

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - sertraline hydrochloride 111.9mg equivalent to 100 mg sertraline;   - film coated tablet - 100 mg - active: sertraline hydrochloride 111.9mg equivalent to 100 mg sertraline   excipient: calcium hydrogen phosphate hyprolose hypromellose macrogol 400 magnesium stearate microcrystalline cellulose polysorbate 80 sodium starch glycolate titanium dioxide - sertraline actavis is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - sertraline hydrochloride 55.95mg equivalent to 50 mg sertraline;   - film coated tablet - 50 mg - active: sertraline hydrochloride 55.95mg equivalent to 50 mg sertraline   excipient: calcium hydrogen phosphate hyprolose hypromellose macrogol 400 magnesium stearate microcrystalline cellulose polysorbate 80 sodium starch glycolate titanium dioxide - sertraline actavis is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

Malta - Kiingereza - Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - tick, borne encephalitis, virus - suspension for injection - tick-borne encephalitis virus 1,2 - vaccines

Israeli - Kiingereza - Ministry of Health

megapharm ltd - hydrocortisone acetate; pramocaine hydrochloride - foam - pramocaine hydrochloride 0.9363 %w/w; hydrocortisone acetate 0.9363 %w/w - relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

ltt pharma limited - sertraline hydrochloride - film coated tablet - 100 milligram

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

ltt pharma limited - sertraline hydrochloride - film coated tablet - 50 milligram

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - metoprolol tartrate -